1. Home
  2. IMCC vs ACON Comparison

IMCC vs ACON Comparison

Compare IMCC & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IM Cannabis Corp.

IMCC

IM Cannabis Corp.

HOLD

Current Price

$0.48

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Logo Aclarion Inc.

ACON

Aclarion Inc.

HOLD

Current Price

$3.27

Market Cap

3.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMCC
ACON
Founded
1980
2008
Country
Israel
United States
Employees
N/A
6
Industry
Medicinal Chemicals and Botanical Products
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
3.5M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
IMCC
ACON
Price
$0.48
$3.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
89.4K
71.2K
Earning Date
05-14-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$47.12
$87.22
Revenue Next Year
$12.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$2.34
52 Week High
$7.12
$15.08

Technical Indicators

Market Signals
Indicator
IMCC
ACON
Relative Strength Index (RSI) 28.38 53.11
Support Level N/A $2.38
Resistance Level $1.55 $3.52
Average True Range (ATR) 0.09 0.21
MACD -0.01 0.03
Stochastic Oscillator 3.47 48.67

Price Performance

Historical Comparison
IMCC
ACON

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Share on Social Networks: